Neupogen and Colonoscopy - a phase IV clinical study of FDA data
Summary:
Colonoscopy is reported as a side effect among people who take Neupogen (filgrastim), especially for people who are female, 50-59 old, also take Zometa, and have Anaemia.
The phase IV clinical study analyzes which people have Colonoscopy when taking Neupogen. It is created by eHealthMe based on reports of 23,793 people who have side effects when taking Neupogen from the FDA, and is updated regularly.
What is Neupogen?
Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.
What is Colonoscopy?
Colonoscopy is found to be associated with 373 drugs and 375 conditions by eHealthMe. Check the latest studies of Colonoscopy.
23,793 people reported to have side effects when taking Neupogen.
Among them, 13 people (0.05%) have Colonoscopy.
Among these 13 people:
What is the gender of people who have Colonoscopy when taking Neupogen? *
- female: 83.33 %
- male: 16.67 %
What is the age of people who have Colonoscopy when taking Neupogen? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
What are other drugs people take besides Neupogen? *
- Zosyn: 11 people, 84.62%
- Nasonex: 11 people, 84.62%
- Amoxicillin: 11 people, 84.62%
- Aranesp: 11 people, 84.62%
- Aredia: 11 people, 84.62%
- Celebrex: 11 people, 84.62%
- Chantix: 11 people, 84.62%
- Compazine: 11 people, 84.62%
- Cytoxan: 11 people, 84.62%
- Zometa: 11 people, 84.62%
What are other side effects people have besides Colonoscopy? *
- Abdominal Pain: 11 people, 84.62%
- Mucosal Inflammation (infection of mucous membrane): 11 people, 84.62%
- Pain: 11 people, 84.62%
- Osteomyelitis (infection of bone): 11 people, 84.62%
- Dehydration (dryness resulting from the removal of water): 11 people, 84.62%
- Discomfort: 11 people, 84.62%
- Nausea And Vomiting: 11 people, 84.62%
- Nausea (feeling of having an urge to vomit): 11 people, 84.62%
- Emotional Distress: 11 people, 84.62%
- Decreased Interest: 11 people, 84.62%
What are the existing conditions these people have? *
- Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 11 people, 84.62%
- Anaemia (lack of blood): 11 people, 84.62%
- Multiple Myeloma (cancer of the plasma cells): 10 people, 76.92%
- Metastases To Bone (cancer spreads to bone): 1 person, 7.69%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Neupogen and have Colonoscopy?
- Check whether Colonoscopy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Neupogen:
- Neupogen (23,898 reports)
Colonoscopy treatments and more:
- Colonoscopy (14,270 reports)
How severe was Colonoscopy and when was it recovered:
Expand to all the drugs that have ingredients of filgrastim:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Neupogen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Colonoscopy:
- Colonoscopy (373 drugs)
Browse all the conditions that are associated with Colonoscopy:
- Colonoscopy (375 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on filgrastim (the active ingredients of Neupogen) and Neupogen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
No recent updates.